BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 8642262)

  • 1. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
    J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription.
    Walsh MJ; Shue G; Spidoni K; Kapoor A
    J Biol Chem; 1995 Mar; 270(10):5289-98. PubMed ID: 7534293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle.
    Oswald F; Dobner T; Lipp M
    Mol Cell Biol; 1996 May; 16(5):1889-95. PubMed ID: 8628255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
    Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the cyclin E gene by transcription factor E2F1.
    Ohtani K; DeGregori J; Nevins JR
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12146-50. PubMed ID: 8618861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F.
    Ohtani K; Tsujimoto A; Ikeda M; Nakamura M
    Oncogene; 1998 Oct; 17(14):1777-85. PubMed ID: 9778043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts.
    Dimri GP; Hara E; Campisi J
    J Biol Chem; 1994 Jun; 269(23):16180-6. PubMed ID: 8206919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
    Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL
    Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis.
    Hiebert SW; Packham G; Strom DK; Haffner R; Oren M; Zambetti G; Cleveland JL
    Mol Cell Biol; 1995 Dec; 15(12):6864-74. PubMed ID: 8524253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
    Shan B; Lee WH
    Mol Cell Biol; 1994 Dec; 14(12):8166-73. PubMed ID: 7969153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1.
    Wu CL; Classon M; Dyson N; Harlow E
    Mol Cell Biol; 1996 Jul; 16(7):3698-706. PubMed ID: 8668186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
    Ohtani K; Iwanaga R; Nakamura M; Ikeda M; Yabuta N; Tsuruga H; Nojima H
    Oncogene; 1999 Apr; 18(14):2299-309. PubMed ID: 10327050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM; Ruscetti FW; Kim SJ; Fu T; Gou FV; Birchenall-Roberts MC
    Cancer Res; 1997 Jul; 57(13):2668-75. PubMed ID: 9205075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.